Company / Revenue
Danaher Corporation Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$24.6B
FY2025
5-year range
$17.9B / $24.8B
FY2021-FY2025
Trend
+2.9%
vs FY2024
Sector context
#15 of 156
Health Care
What the data says
Among 156 Health Care companies, Danaher Corporation is in the top 10% for revenue. Revenue has fluctuated over the past 10 years, ranging from $16.9B in FY2016 to $24.8B in FY2023.
Based on SEC 10-K filings.
$24.6B in FY2025 with a 5-year CAGR of +7.6%. Top quartile in the Health Care sector.
Remained stable around $24.6B over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +3.3%
- 5-Year CAGR
- +7.6%
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 156This company $24.6B Sector average $19.0B
▼
+29.3% above sector average
Key checks
Key Insights
- 5-year CAGR of +7.6%, indicating consistent growth.
- In FY2025, revenue increased 2.9% year-over-year.
- Ranks #15 out of 156 companies in the Health Care sector.
- Peak revenue was recorded in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $24.6B | +2.9% |
| FY2024 | $23.9B | -3.7% |
| FY2023 | $24.8B | +11.3% |
| FY2022 | $22.3B | +24.4% |
| FY2021 | $17.9B | +5.1% |
| FY2020 | $17.0B | -4.8% |
| FY2019 | $17.9B | -10.0% |
| FY2018 | $19.9B | +8.5% |
| FY2017 | $18.3B | +8.6% |
| FY2016 | $16.9B | +17.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026